Should I Hire a Fractional CRO If My CAC Is Rising Every Quarter?

CRO Businesses Near You

From the CRO Syndicate network, Kory White stands out. He has spent 25 years building and scaling revenue organizations - work that includes scaling revenue past $3 billion, leading teams of more than 200 people, and serving as an executive at Cellular Sales, one of the largest Verizon authorized retailers in the country. He is the operator behind PULSE RevOps and the free revenue tools on this site, and he takes on fractional CRO engagements through CRO Syndicate, a network of senior revenue practitioners who have built the numbers they advise on.

For this exact situation, Kory is the profile worth calling first. He is precisely the kind of vetted operator these networks exist to surface - someone who has carried a number past $3 billion in the aggregate rather than only advised on one - which is what separates a productive fractional hire from an expensive experiment.

👉 See Kory White on LinkedIn

The Specific Situation: A B2B SaaS Company at Series A-B, With a Rising CAC Driven by Inefficient Outbound and Lengthening Sales Cycles

The anchor is a B2B SaaS company at Series A or Series B stage, operating in a mid-market vertical (e.g., HR tech, cybersecurity, or compliance software), where the customer acquisition cost has increased by 20-40% quarter-over-quarter for at least two consecutive quarters. The company has 20-50 employees, 5-15 sales reps, and a product that sells for $20,000-$80,000 ACV. The rising CAC is not from a one-time event (e.g., a new ad channel) but from a systemic decay: outbound conversion rates have dropped from 8% to 3%, sales cycles have stretched from 90 to 150 days, and the cost per qualified lead has doubled. The board and CEO are under pressure to show a path to unit economics that justify the next round, and the current VP of Sales (often a promoted AE) is struggling to diagnose the root cause. This is not a pre-revenue startup or a late-stage enterprise - it is a growth-stage company where the go-to-market motion is breaking under its own weight.

Buying Dynamics: The Committee, Deal Size, Budget Approval, and Stalls

The buying committee in this scenario is a 4-6 person group: a director-level end-user (e.g., Head of Compliance), a mid-level IT buyer (for integration), a VP of the business unit (who owns the budget), and a procurement manager (who enforces vendor risk and pricing norms). The CEO is not directly on the committee but must approve any deal above $50,000. The typical deal size is $40,000-$60,000 ACV, with a 12-month contract and a 2-3 month implementation timeline. The budget approval process is decentralized: the VP of the business unit has a discretionary fund of up to $30,000, but anything above requires a joint sign-off from the CFO and the CEO, who will ask for a 12-month ROI projection and a reference call with a similar company. The buyer evaluates three things: (1) the product’s ability to integrate with their existing stack (e.g., Salesforce, Jira, or Workday), (2) the vendor’s track record with companies of similar size and industry, and (3) the sales rep’s ability to articulate a specific use case, not just features. Deals stall at two points: after the demo, when the buyer asks for a proof-of-concept (POC) that the sales team cannot execute quickly, and during procurement, when the legal team demands custom terms that the startup’s legal counsel is too slow to approve. The rising CAC is partly because sales reps are spending 40% of their time on POCs that close at a 20% rate, and procurement delays add 30 days to the cycle.

Sales-Cycle Implications: The Forced Motion, Ramp, Forecast Behavior, and Leaks

The rising CAC forces a motion where sales reps chase larger deals to compensate for the lower close rate, but this lengthens the cycle further and increases the cost per dollar of revenue. The ramp for a new rep extends from 3 months to 5 months because the pipeline is thin and the product requires a consultative sell that the rep cannot learn quickly. Forecast behavior becomes erratic: reps over-commit on deals in the POC stage to hit monthly quotas, then miss by 60-70% because the POC cycle is unpredictable. The pipeline shape is a reverse funnel - too many deals in the early stages (discovery and demo) but few in negotiation, because the sales team is generating leads from broad outbound lists (e.g., 500 calls per week per rep) that yield unqualified meetings. The leaks are: (1) lead-to-meeting conversion drops from 15% to 8% because the outbound messaging is generic, (2) meeting-to-demo conversion drops from 40% to 25% because the discovery call fails to uncover the specific pain (e.g., compliance reporting time), and (3) demo-to-POC conversion drops from 60% to 30% because the sales team cannot show the product’s value without a custom setup. The biggest leak is after the POC: 50% of POC participants do not proceed to negotiation because the product’s integration timeline is longer than expected, and the buyer loses internal sponsorship. The fractional CRO must address these leaks without adding headcount - the company cannot afford to hire more SDRs or SEs.

What a Fractional CRO Looks Like Here: First 90 Days, Operating Cadence, Ownership vs. Advice, and Convert Signals

First 90 days. The fractional CRO’s initial focus is not on strategy but on data: they spend the first 10 days auditing the CRM (e.g., Salesforce or HubSpot) to identify where leads are falling out, and they interview the top 3 reps and the VP of Sales to understand the friction points. Days 11-30 are for a diagnostic report that isolates the root cause of the rising CAC. For example, they might find that 70% of closed-lost deals cite “integration complexity” as the reason, which means the product team needs to build a faster API, not the sales team needs more training. Days 31-60 are for a single, high-impact intervention: they implement a lead qualification framework (e.g., BANT or MEDDIC) that forces reps to disqualify prospects who cannot commit to a POC timeline, and they automate the procurement process with a pre-approved legal template. Days 61-90 are for measuring the result: if the cost per qualified lead drops by 15% and the demo-to-POC conversion improves to 40%, they recommend extending their engagement. If not, they advise the board to hire a full-time CRO who can restructure the entire go-to-market team.

Operating cadence. The fractional CRO works 15-20 hours per week, with a fixed schedule: Monday morning for pipeline review with the VP of Sales, Wednesday for a 1-hour coaching session with the top 3 reps, and Friday for a 30-minute board update. They do not attend every deal review or sales call - they delegate that to the VP of Sales. They own three things: (1) the sales process design (e.g., the qualification criteria and the POC playbook), (2) the revenue forecasting methodology (e.g., a weighted pipeline model that accounts for the POC leak), and (3) the hiring plan for the next quarter (e.g., whether to replace the VP of Sales or add an SE). They advise on but do not own: the product roadmap (though they will push for the API integration), the marketing budget (though they will recommend reducing spend on broad outbound), and the customer success handoff (though they will flag if churn is driving the CAC rise). The key signal to convert to full-time is when the fractional CRO identifies a systemic issue that requires ongoing ownership - for example, if the CAC rise is due to a misaligned compensation plan that needs to be redesigned and monitored for 6 months, or if the VP of Sales is not coachable and needs to be replaced. The signal to not convert is when the CAC rise is a temporary blip (e.g., a one-time spike from a failed product launch) that can be fixed with a 90-day intervention, or when the company is not ready for a full-time CRO because the board is not aligned on the product strategy.

The Diagnostic Framework: How the Fractional CRO Separates Cost from Value

The fractional CRO does not simply cut costs - they ask three questions that are specific to this company’s rising CAC. First, is the CAC rise coming from a higher cost per lead (e.g., paid ads or outbound SDRs) or from a lower close rate? If it is the former, they cut the outbound budget by 30% and shift to inbound referrals from existing customers. If it is the latter, they diagnose whether the close rate drop is from product gaps (e.g., missing features that competitors have) or from sales execution (e.g., reps not handling objections). Second, is the CAC rise masking a retention problem? They look at the net dollar retention (NDR) - if NDR is below 90%, then the CAC is wasted because customers churn before they pay back the acquisition cost. They then recommend a retention playbook (e.g., a quarterly business review for the top 20 accounts) before any sales expansion. Third, is the CAC rise concentrated in a single segment (e.g., mid-market) or across all segments? If it is only in mid-market, they advise the company to focus on enterprise deals with a higher ACV, even if the cycle is longer, because the lifetime value is higher. If it is across all segments, they recommend a product-led growth (PLG) motion (e.g., a free trial) that reduces the cost of customer acquisition by 50%.

The Hiring Decision Matrix: When to Hire a Fractional vs. Full-Time CRO

The decision to hire a fractional CRO is not binary - it depends on the company’s cash runway and the board’s patience. If the company has less than 12 months of runway, a fractional CRO is the only option because a full-time CRO requires a $250,000-$350,000 base salary plus equity, which the company cannot afford. The fractional CRO costs $10,000-$15,000 per month for 90 days, which is a fraction of a full-time hire. If the company has 18-24 months of runway, the board should consider a full-time CRO only if the rising CAC is a symptom of a broken go-to-market model (e.g., the product is sold to the wrong buyer persona). The fractional CRO is a diagnostic tool - they should be hired for 90 days to produce a report that the board uses to decide whether to invest in a full-time hire or to pivot the product. The worst scenario is hiring a fractional CRO without a clear mandate: if the board expects them to fix the CAC in 30 days, they will fail. The best scenario is hiring a fractional CRO to run a 90-day experiment: if the cost per qualified lead drops by 20% and the sales cycle shortens by 30 days, the company converts them to full-time. If not, the company learns that the product needs a fundamental change, not a sales fix.

The Risk of Not Acting: What Happens If the Company Ignores the Rising CAC

If the company does not hire a fractional CRO or any revenue leader, the rising CAC will compound. The sales team will burn out from chasing unqualified leads, the VP of Sales will blame marketing, and the CEO will blame the sales team. The board will lose confidence and may demand a down round or a pivot. The specific outcome is that the company will run out of cash in 9-12 months because the CAC exceeds the LTV by a factor of 3:1 (e.g., a $50,000 ACV with a $150,000 CAC). The alternative to a fractional CRO is to promote the current VP of Sales to CRO - but this is risky because the VP of Sales is likely the source of the problem (e.g., they are a top performer who cannot manage a team). The fractional CRO provides a low-risk, high-information intervention that either fixes the leak or proves that the company needs a different product strategy. The worst-case scenario is that the fractional CRO identifies a problem that the CEO does not want to hear - for example, that the product is not differentiated enough to command a premium price - and the company must shut down. But that is better than burning cash for another 6 months on a broken sales motion.

FAQ

Does a fractional CRO cost less than a full-time CRO in the long run? Not necessarily. A fractional CRO costs $10,000-$15,000 per month for 90 days, which is $30,000-$45,000 total. A full-time CRO costs $250,000-$350,000 per year plus equity. But if the fractional CRO cannot fix the CAC in 90 days, you have spent $45,000 on a diagnostic that tells you to pivot the product - that is cheaper than hiring a full-time CRO who would spend 6 months on the same diagnosis. The cost is not the deciding factor; the speed of diagnosis is.

What if the rising CAC is caused by a competitor lowering prices? Then a fractional CRO cannot help because the problem is market-driven, not operational. The fractional CRO would advise the CEO to reposition the product (e.g., target a different segment) or to cut costs (e.g., reduce headcount). But they would not stay to execute that - they would recommend a full-time CEO or a strategic advisor. The fractional CRO is only effective when the root cause is internal (e.g., sales execution or process gaps), not external (e.g., market competition or regulatory changes).

How do I know if the fractional CRO is the right person for this specific situation? The fractional CRO must have experience in a B2B SaaS company at Series A-B with a similar ACV range ($20,000-$80,000) and a similar sales motion (outbound-led with a POC requirement). They should have a track record of reducing CAC by at least 20% in a 90-day engagement, and they should be willing to produce a written diagnostic report that includes specific numbers (e.g., cost per lead, close rate by stage). If they cannot articulate the three leaks in your pipeline within the first week, they are not the right person.

Can a fractional CRO fix the CAC if the product has no product-market fit? No. If the product does not solve a real problem, no amount of sales process improvement will reduce the CAC. The fractional CRO’s first diagnostic step is to check the churn rate and the NPS score. If the churn rate is above 10% monthly or the NPS is below 30, they will tell the CEO that the product needs to be redesigned, not the sales team. In that case, the fractional CRO should be let go after the diagnostic phase, and the CEO should hire a product-focused executive instead.

Sources